Related Experiment Video
Updated: Oct 24, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders
Tracey A Cheves1, Sandra DeMarinis1, Joseph D Sweeney1
1Coagulation and Transfusion Medicine, Rhode Island Hospital and Warren Alpert School of Medicine at Brown University, 593 Eddy Street, Providence, RI 02903, USA.
Diagnosing hereditary bleeding disorders involves a tiered testing approach, starting with basic tests and progressing to more detailed assays. Management strategies should be tailored, avoiding empiric blood component therapy.
Area of Science:
- Hematology
- Clinical Diagnostics
- Hereditary Diseases
Background:
- Suspected hereditary bleeding disorders require a systematic diagnostic evaluation.
- Accurate diagnosis is crucial for effective patient management and treatment.
- A significant number of patients may not show demonstrable hemostatic abnormalities.
Purpose of the Study:
- To outline a structured, tiered approach for diagnosing hereditary bleeding disorders.
- To guide clinicians in selecting appropriate diagnostic tests based on patient presentation.
- To provide recommendations for managing patients with suspected bleeding disorders.
Main Methods:
- Initial assessment includes a detailed bleeding history.
- Tiered laboratory testing begins with platelet count, morphology, histogram, PFA-100, fibrinogen, prothrombin time, and activated partial thromboplastin time.
- Further investigations involve von Willebrand factor assays, individual clotting factor assays, and advanced platelet function tests.
Main Results:
- A stepwise diagnostic process is effective in identifying various bleeding abnormalities.
- Specific tests are employed to detect dysfibrinogenemia, Factor XIII deficiency, or fibrinolytic defects.
- A subset of patients may present with unexplained hemostatic abnormalities despite comprehensive testing.
Conclusions:
- A tiered diagnostic strategy ensures thorough evaluation of suspected hereditary bleeding disorders.
- Management may involve specific therapies like desmopressin or antifibrinolytics.
- Empiric use of blood component therapy is not recommended and should be avoided.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

